Nature Reviews Clinical Oncology - Zoledronic acid is effective in the prevention of bone loss in premenopausal women with breast cancer being treated with endocrine therapy. The benefit of ...
A proof-of-concept trial has shown that zoledronic acid is effective in preventing bone erosions in patients with early rheumatoid arthritis (RA). Zoledronic acid is a third-generation ...
Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.
Subcutaneous; SRE: Skeletal-related event; SSE: Symptomatic skeletal event; Z4: Zoledronic acid 4 mg every 3 weeks; Z8: Zoledronic acid 8 mg every 3 weeks. Androgen deprivation is the mainstay of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback